Dan Furman explains why the biggest opportunity in neurotechnology may not be new hardware, but the software layer that can decode brain signals in real time and make them useful across health, education, entertainment, and human-computer interaction.

A non-surgical brain–computer interface built with nanoparticles. Tetiana Aleksandrova, Founder & CEO of Subsense, shares how her team is aiming for invasive-level accuracy without surgery and why she believes BCIs will become one of the biggest technology revolutions of our lifetime.

Omari Bouknight, CEO of Resonant Link Medical, shares how his team is building the wireless backbone for the next generation of implantable devices — from neurostimulation and BCI to cardiac care. In this exclusive interview, he discusses the company’s journey, the Orion platform’s core innovations, and what it takes to bring high-performance power and data transfer into the body.

From lab to clinic, NeuroBionics is redefining neuromodulation with flexible, vascular‑based neural interfaces. In this interview, co‑founder Nicolette Driscoll shares her journey, the technical breakthroughs behind their evStim device, and how they’re pushing neurotechnology forward.

Sam Hosovsky, CEO of uCat, shares his journey into neurotechnology and how his company is transforming brain-computer interface (BCI) development through VR-based training and avatar embodiment. Discover how uCat is helping redefine clinical adoption of BCIs.